Lupus Low Disease Activity State Attainment in the Phase 3 TULIP Trials of Anifrolumab in Active Systemic Lupus Erythematosus
Annals of the Rheumatic Diseases（2023）
Key words
autoimmune diseases,biological therapy,glucocorticoids,lupus erythematosus,systemic
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined